Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy
Kazuhiro Koikawa(Beth Israel Deaconess Medical Center), Shin Kibe(Broad Institute), Futoshi Suizu(Beth Israel Deaconess Medical Center), Nobufumi Sekino(Broad Institute), Nami Kim(Beth Israel Deaconess Medical Center), Theresa Manz(Harvard University), Benika J. Pinch(Harvard University), Dipikaa Akshinthala(Beth Israel Deaconess Medical Center), Ana Verma(Brigham and Women's Hospital), Giorgio Gaglia(Brigham and Women's Hospital), Yutaka Nezu(Beth Israel Deaconess Medical Center), Shizhong Ke(Broad Institute), Chenxi Qiu(Broad Institute), Kenoki Ohuchida(Kyushu University), Yoshinao Oda(Kyushu University), Tae Ho Lee(Beth Israel Deaconess Medical Center), Babara Wegiel(Beth Israel Deaconess Medical Center), John G. Clohessy(Beth Israel Deaconess Medical Center), Nir London(Weizmann Institute of Science), Sandro Santagata(Brigham and Women's Hospital), Gerburg M. Wulf(Beth Israel Deaconess Medical Center), Manuel Hidalgo(Beth Israel Deaconess Medical Center), Senthil K. Muthuswamy(Beth Israel Deaconess Medical Center), Masafumi Nakamura(Kyushu University), Nathanael S. Gray(Stanford University), Xiao Zhen Zhou(Broad Institute), Kun Ping Lu(Broad Institute)
Cited by 239Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis